In the BioHarmony Drug Report Database
Sincalide
Kinevac (sincalide) is a protein pharmaceutical. Sincalide was first approved as Kinevac on 1982-01-01. It is known to target gastrin/cholecystokinin type B receptor and cholecystokinin receptor type A. Kinevac’s patent is valid until 2022-08-16 (FDA).
Trade Name
|
Kinevac |
|---|---|
Common Name
|
sincalide |
ChEMBL ID
|
CHEMBL1121 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)